LVTX logo

LAVA Therapeutics NV (LVTX) EBITDA

Annual EBITDA

-$40.19 M
-$9.39 M-30.49%

December 31, 2023

Summary

Performance

1-Year Change

-30.49%

3-Year Change

-166.51%

5-Year Change

-330.15%

15-Year Change

-330.15%

LVTX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.24%
LVTX annual EBITDA is higher than 37.24% of companies in Healthcare sector

High & Low

All-time High

-$9.34 M

3-Year Low

-$41.02 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LVTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 20, 2025
LVTX next annual earnings announcement is scheduled for Mar 20, 2025

OtherLVTXprofitabilitymetrics:

Annual Revenue

$6.77 M
LVTX annual revenue is $6.77 million

Annual Net Income

-$41.97 M
LVTX annual net profit is -$41.97 million

Annual EBIT

-$41.46 M
LVTX annual earnings before interest & taxes is -$41.46 million

Annual EPS

-$1.57
LVTX annual earnings per share is -$1.57

Quarterly EBITDA

-$11.07 M
-$1.94 M-21.24%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-6.38%

3-Year Change

-6.38%

5-Year Change

-6.38%

LVTX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.42%
LVTX quarterly EBITDA is higher than 34.42% of companies in Healthcare sector

High & Low

All-time High

-$1.40 M

3-Year Low

-$13.25 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LVTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
LVTX next earnings announcement is scheduled for Mar 20, 2025

OtherLVTXprofitabilitymetrics:

Quarterly Revenue

-
LVTX quarterly revenue value is unknown

Quarterly Net Income

-$12.30 M
LVTX quarterly net profit is -$12.30 million

Quarterly EBIT

-$11.29 M
LVTX quarterly earnings before interest & taxes is -$11.29 million

Quarterly EPS

-$0.46
LVTX quarterly earnings per share is -$0.46

TTM EBITDA

-$25.21 M
-$664.00 K-2.71%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+43.76%

3-Year Change

+43.76%

5-Year Change

+43.76%

LVTX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.68%
LVTX TTM EBITDA is higher than 45.68% of companies in Healthcare sector

High & Low

All-time High

-$3.96 M

3-Year Low

-$44.83 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LVTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
LVTX next earnings announcement is scheduled for Mar 20, 2025

OtherLVTXprofitabilitymetrics:

TTM Revenue

-
LVTX TTM revenue value is unknown

TTM Net Income

-$27.64 M
LVTX TTM net profit is -$27.64 million

TTM EBIT

-$26.25 M
LVTX TTM earnings before interest & taxes is -$26.25 million

TTM EPS

-$1.01
LVTX TTM earnings per share is -$1.01

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$40.19 M
LVTX annual EBITDA is -$40.19 million

Annual Net Income

-$41.97 M
LVTX annual net profit is -$41.97 million

Annual Interest Expense

$232.00 K
LVTX annual interest expense is $232.00 thousand

Annual Income Tax

$279.00 K
LVTX annual income tax is $279.00 thousand

Annual D&A

$1.28 M
LVTX annual depreciation & amortization is $1.28 million

LVTX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.5%-6.4%+43.8%
3 y3 years-166.5%-6.4%+43.8%
5 y5 years-330.1%-6.4%+43.8%

LVTX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-30.5%+2.0%-689.2%+16.4%-2.7%+43.8%
5 y5-year-330.1%+2.0%-689.2%+43.1%-537.1%+43.8%
alltimeall time-330.1%+2.0%-689.2%+43.1%-537.1%+43.8%

LAVA Therapeutics NV EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$11.07 M(+21.2%)
-$25.21 M(+2.7%)
Jun 2024
-
-$9.13 M(+435.7%)
-$24.55 M(-14.4%)
Mar 2024
-
-$1.71 M(-48.3%)
-$28.66 M(-28.7%)
Dec 2023
-$40.19 M(+30.5%)
-$3.30 M(-68.3%)
-$40.19 M(-10.4%)
Sep 2023
-
-$10.41 M(-21.4%)
-$44.83 M(+25.1%)
Jun 2023
-
-$13.25 M(+0.2%)
-$35.83 M(+7.0%)
Mar 2023
-
-$13.23 M(+66.4%)
-$33.48 M(+8.7%)
Dec 2022
-$30.80 M
-$7.95 M(+466.4%)
-$30.80 M(+2.6%)
Sep 2022
-
-$1.40 M(-87.1%)
-$30.00 M(-18.5%)
Jun 2022
-
-$10.90 M(+3.4%)
-$36.81 M(+9.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$10.54 M(+47.4%)
-$33.60 M(-21.0%)
Dec 2021
-$41.02 M(+172.0%)
-$7.15 M(-13.0%)
-$42.51 M(+10.4%)
Sep 2021
-
-$8.22 M(+6.9%)
-$38.50 M(+13.1%)
Jun 2021
-
-$7.68 M(-60.5%)
-$34.05 M(+12.9%)
Mar 2021
-
-$19.46 M(+520.6%)
-$30.15 M(+105.8%)
Dec 2020
-$15.08 M(+61.4%)
-$3.14 M(-16.8%)
-$14.65 M(+27.2%)
Sep 2020
-
-$3.77 M(-0.5%)
-$11.52 M(+48.7%)
Jun 2020
-
-$3.79 M(-4.2%)
-$7.75 M(+95.8%)
Mar 2020
-
-$3.96 M
-$3.96 M
Dec 2019
-$9.34 M
-
-

FAQ

  • What is LAVA Therapeutics NV annual EBITDA?
  • What is the all time high annual EBITDA for LAVA Therapeutics NV?
  • What is LAVA Therapeutics NV annual EBITDA year-on-year change?
  • What is LAVA Therapeutics NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for LAVA Therapeutics NV?
  • What is LAVA Therapeutics NV quarterly EBITDA year-on-year change?
  • What is LAVA Therapeutics NV TTM EBITDA?
  • What is the all time high TTM EBITDA for LAVA Therapeutics NV?
  • What is LAVA Therapeutics NV TTM EBITDA year-on-year change?

What is LAVA Therapeutics NV annual EBITDA?

The current annual EBITDA of LVTX is -$40.19 M

What is the all time high annual EBITDA for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high annual EBITDA is -$9.34 M

What is LAVA Therapeutics NV annual EBITDA year-on-year change?

Over the past year, LVTX annual EBITDA has changed by -$9.39 M (-30.49%)

What is LAVA Therapeutics NV quarterly EBITDA?

The current quarterly EBITDA of LVTX is -$11.07 M

What is the all time high quarterly EBITDA for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high quarterly EBITDA is -$1.40 M

What is LAVA Therapeutics NV quarterly EBITDA year-on-year change?

Over the past year, LVTX quarterly EBITDA has changed by -$664.00 K (-6.38%)

What is LAVA Therapeutics NV TTM EBITDA?

The current TTM EBITDA of LVTX is -$25.21 M

What is the all time high TTM EBITDA for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high TTM EBITDA is -$3.96 M

What is LAVA Therapeutics NV TTM EBITDA year-on-year change?

Over the past year, LVTX TTM EBITDA has changed by +$19.62 M (+43.76%)